ACM
IDXX icon

Armbruster Capital Management’s Idexx Laboratories IDXX Stock Holding History

Armbruster Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33
Closed -$6K – 129
2018
Q1 		$6K Hold
33
– – ﹤0.01% 193
2017
Q4 		$5K Hold
33
– – ﹤0.01% 227
2017
Q3 		$5K Hold
33
– – ﹤0.01% 219
2017
Q2 		$5K Hold
33
– – ﹤0.01% 239
2017
Q1 		$5K Hold
33
– – ﹤0.01% 236
2016
Q4 		$4K Buy
+33
New +$3.77K ﹤0.01% 257

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FEF
Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Armbruster Capital Management's IDXX Position: Q2 2018 in Review

Armbruster Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2018, closing a stake of 33 shares — an estimated $6K sold.

Armbruster Capital Management first reported a position in IDXX in Q4 2016 and held it in 6 quarters. The position peaked at $6K in Q1 2018. 665 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

  • Armbruster Capital Management reported no remaining Idexx Laboratories position as of Q2 2018 after selling out during the quarter.
  • Armbruster Capital Management sold 33 Idexx Laboratories shares in Q2 2018, an estimated $6K.
  • Armbruster Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 6 quarters.
  • Armbruster Capital Management's Idexx Laboratories position peaked at $6K in Q1 2018.
  • 665 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Armbruster Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.